| Median levels of haemostatic proteins in plasma | |||||
---|---|---|---|---|---|---|
 | Baseline | After viral infection | ||||
 | Control n = 11 | Asthma n = 13 | p-value between groups at baseline | Control n = 11 | Asthma n = 13 | p-value between groups after viral infection |
Markers of coagulation | ||||||
TATc (ng/mL) | 2.4 (1.5–4.0) | 1.5 (1.4–1.5) | 0.02 | 1.95 (1.6–2.3) | 1.4 (1.3–1.5) | 0.03 |
vWF (% of pooled plasma) | 77.0 (60.0–89.0) | 99.0 (84.0–127.0) | 0.07 | 87.0 (65.0–148.0) | 127.0 (87.0–148.0) | 0.19 |
D-dimer (ng/mL) | 221 (112–422) | 146 (127–173) | 0.39 | 143 (113–317) | 163 (144–230) | 1.00 |
ETP (nM.min) | 1653 (1340–1663) | 1446 (1290–1644) | 0.25 | 1660 (1351–1743) | 1494 (1321–1645) | 0.19 |
Markers of fibrinolysis | ||||||
PAP (ng/mL) | 385 (261–618) | 327 (276–391) | 0.17 | 534 (311–786) | 320 (303–467) | 0.047 |
PAI-1 (ng/mL) | 13.0 (11.0–21.0) | 16.0 (12.0–24.0) | 0.28 | 11.5 (9.0–16.0) | 26.0 (15.0–33.0)* | 0.04 |